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In order to better understand the immunoregulation following Mycobacterium tuberculosis infection, cytokine
mRNA induction in response to in vitro infection of human monocytes with live virulent M. tuberculosis H37Rv
cocultured with autologous lymphocytes was quantitated by reverse transcriptase-PCR. Induced levels of
interleukin 10 (IL-1,8), IL-2, tumor necrosis factor alpha, and gamma interferon (IFN-7y) were compared
among groups of individuals representing three phases of immunity to infection with M. tuberculosis: naive
normal control subjects, purified protein derivative (PPD)-reactive normal donors, and individuals with active
tuberculosis (TB [diseased]). Levels of IL-1, and tumor necrosis factor alpha mRNA in cocultured cells from
TB patients were 51 and 45%, respectively, of those obtained in cells from sensitized healthy volunteers and
were comparable to those from naive normal donors. Lymphoproliferative responses to M. tuberculosis and
induction of the T-cell cytokine IL-2 were predictably high in the cells of PPD-sensitized donors, low in normal
naive individuals, and variable among TB patients. In contrast, the induced level of another lymphokine,
IFN--y, did not follow the pattern seen in IL-2 induction. Infection with live M. tuberculosis induced high levels
of IFN-y mRNA in lymphocytes of both PPD-sensitized and normal naive donors compared with those of TB
patients. Interestingly, polyclonal stimulation with the mitogen concanavalin A induced similar IFN--y levels in
cells from all three donor groups. The high level of IFN-y induced by the infection of monocytes from naive
normal donors suggests a role for natural killer (NK) cells in the production of IFN-y in this coculture system.
This response appears independent of the role performed by T cells.
Tuberculosis (TB) remains an important cause of morbidity
and mortality worldwide. Currently, the human immunodefi-
ciency virus pandemic and the emergence of multiply-drug-
resistant forms of Mycobacterium tuberculosis threaten to
overwhelm control strategies (3). On exposure to the bacte-
rium, most healthy individuals successfully contain the infec-
tion and go on to develop a vigorous cell-mediated immune
response and a delayed-type hypersensitivity reaction to my-
cobacterial antigens. The protective immune response depends
on the cooperation between infected macrophages, activated T
lymphocytes, activated natural killer (NK) cells, and their
induced cytokines (16). However, a disfunctional cell-mediated
immune response to infection with M. tuberculosis may con-
tribute to progressive primary infection or reactivation of
endogenous foci of mycobacteria (5).
In vitro stimulation of leukocytes with mycobacteria or their
products induces synthesis and release of several cytokines,
including interleukin 1 (IL-1), IL-2, IL-6, tumor necrosis factor
alpha (TNF-oL), and gamma interferon (IFN--y) (9, 17, 23, 24,
26, 29, 32). Among the T-cell cytokines produced within the
granulomatous lesion, IL-2 and IFN-y have important func-
tions. Antigen stimulation of the T-cell receptor induces
transcription of IL-2 and IL-2 receptor genes, which then
signal clonal expansion of activated T cells (as well as NK and
B cells) and the production of other cell-regulating factors (7).
IL-2 also plays a key role in the generation of the cytokine
cascade, with pleiotropic effects including lymphocyte prolifer-
ation. This lymphokine is also indirectly chemotactic for leu-
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kocytes, eliciting extravasation by inducing a change in the
adhesive properties of endothelial cells (19). IFN--y is respon-
sible for activation of monocytes and stimulation of giant cell
formation (10). IFN-,y has also been shown to inhibit intracel-
lular growth of mycobacteria (8) and may exert its effects
indirectly by inducing synthesis of the tuberculostatic 1,25-
dihydroxyvitamin D3 from its inactive precursor (15).
IL-1 probably plays a key role in the development of the
hypersensitivity granuloma (18). Multiple biologic activities of
this monokine include induction of IL-2 and IL-2 receptor in T
cells and the promotion of IL-3 and IL-6 synthesis by mono-
cytes. While IL-1 production is augmented during the early
elicitation phase of granuloma development, production of
TNF-ot increases during the late recruitment and maintenance
phases (10). Some of the activities ascribed to TNF-ct include
upregulated HLA expression, enhanced IFN--y-induced Ia
expression, and induction of IL-6 production (21).
It has been reported that peripheral blood mononuclear
cells (PBMCs) from TB patients, when stimulated in vitro with
purified protein derivative (PPD), release lower levels of
certain cytokines, including IFN--y and IL-2, than do cells from
healthy donors (11, 24, 32, 33) and higher levels of other
cytokines, including TNF-ao and IL-1 (9).
We evaluated the cytokine response to in vitro infection with
virulent M. tuberculosis at the gene expression level. An in vitro
model of M. tuberculosis-infected human monocyte-T-cell
interaction was used to analyze the kinetics and level of
cytokine induction by measuring specific mRNA accumulation
with reverse transcriptase (RT)-PCR technology. This enabled
us to avoid some of the problems associated with cytokine
detection in a biological assay such as lability, low concentra-
tion, and receptor-mediated uptake. Quantitation of these
mRNA species allowed us to compare cytokine responses
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among groups of individuals representing three phases of
immunity to M. tuberculosis.
(This work was presented in part at the 1992 Federation of
American Societies for Experimental Biology meeting, Ana-
heim, Calif., 5 to 9 April 1992, and at the 92nd General
Meeting of the American Society for Microbiology, New
Orleans, La., 26 to 30 May 1992 [hla].)
MATERIALS AND METHODS
Human subjects. Venous blood samples were collected from
PPD-reactive and nonreactive healthy volunteers and TB
patients. TB patients from the Veterans Administration Hos-
pitals in Temple and Houston, Tex., had been diagnosed on
the basis of the demonstration of acid-fast bacilli in the
sputum, and diagnosis of TB had been confirmed by a culture
positive for M. tuberculosis. The patients were undergoing
anti-TB drug treatment at the time blood samples were taken.
All volunteers were human immunodeficiency virus type 1 and
hepatitis B seronegative, and most had a history of tuberculin
reactivity. In addition, they had no manifest coinfections or
other conditions which might affect the immune response.
They ranged in age from 43 to 66 years, and all were male.
Normal control subjects were between the ages of 23 and 55
years and were not sex matched with regard to the TB patient
group.
Preparation of leukocytes. Heparinized blood was separated
aseptically and PBMCs were isolated as described previously
(6) and were allowed to adhere for 1 h at 37°C in 5% CO2 in
a humidified atmosphere after which nonadherent (NA) cells
were drawn off. Adherent (AD) cells were routinely in a >90%
monocyte/macrophage ratio, as determined with the nonspe-
cific esterase assay (14). Live, sonicated M. tuberculosis H37Rv
(ATCC 27294) cells were added at approximately 1 bacterium
per 10 AD cells in RPMI medium with 5% autologous serum
and were incubated for 30 min. Medium was removed, the AD
cells were washed vigorously three times to remove extracel-
lular bacteria, and warm RPMI medium with 10% autologous
serum was added back to the cultures. Replicate cultures in
which the AD cells were not infected were set up. The
presence of mycobacteria within AD cells was confirmed by
acid-fast staining of cultures at intervals after infection. AD
cells from the three different study populations (tuberculous,
PPD reactive, and naive) phagocytosed M. tuberculosis with
equivalent efficiency. After a second depletion of AD cells, the
remaining NA cells were added to the AD cultures at an
NA/AD ratio of 2:1 and incubated for 7 days.
Phenotypic analysis. For indirect immunofluorescent stain-
ing, NA cells were taken directly after the second adherence
step or removed from coculture after 7 days and stained with
a saturating amount of the following monoclonal antibodies:
anti-CD3(Leu-4), anti-CD4(Leu-3a), anti-CD8(Leu-2a), anti-
TCRaP(TCR-l,x4PWT31) (Becton-Dickinson, Mountain View,
Calif.), anti-TCR-y8(TCR81) (T Cell Sciences, Cambridge,
Mass.), and anti-CD28(9.3) (a generous gift from Bristol-
Myers Squibb, Seattle, Wash.). Following incubation with a
labeled secondary antibody [fluorescein isothiocyanate-conju-
gated sheep F(ab')2 anti-mouse immunoglobulin (Sigma)],
cells were analyzed with the EPICS V flow cytometer (Coulter
Electronics, Hialeah, Fla.).
Proliferation assay. PBMCs were placed in 96-well flat-
bottom tissue culture dishes (Becton-Dickinson) at 3 x 105
cells per well in RPMI medium with 10% autologous serum
and 5 jig of concanavalin A (ConA [Sigma]) or 5 ,ug of PPD(PPD-RT46, Statens Seruminstitut, Copenhagen, Denmark)
per ml for 6 days. On day 7, 5 ,uCi of [3H]thymidine (ICN
Radiochemicals, Irvine, Calif.) per ml was added for 6 h, after
which cells were harvested onto glass wool fiber filters by
means of a cell harvester (MASH II; MA Bioproducts, Walk-
ersville, Md.). [3H]thymidine incorporation into cellular DNA
was measured by liquid scintillation spectroscopy. All samples
were assayed in triplicate, and the results are expressed as
mean counts per minute. Lymphoproliferation in response to
PPD was considered positive when counts-per-minute values
were more than 2 standard deviations above mean values
obtained in healthy tuberculin-negative donors.
In a preliminary experiment, PPD-reactive donor PBMCs
were tested over a range of cell densities (1 x 105, 3 x 105,
and 5 x 105 cells per well) and concentrations of PPD (5, 10,
25, and 50 ,ug/ml). The optimal response was obtained with
3 x 105 cells per well and 5,ug of PPD per ml. These levels
were used throughout the study.
RNA extraction. Cytoplasmic RNA was extracted from
infected or uninfected cocultured cells at selected time points
postinfection with RNAzol B RNA isolation solvent as de-
scribed by the manufacturer (Cinna/Biotecx, Houston, Tex.).
This method is a variation of the single-step acid guanidinium-
thiocyanate-phenol-chloroform-RNA extraction method (4).
Absorption spectroscopy was used to measure the purity and
concentration of RNA, with an A2601280 ratio of 2.0 indicating
highly purified RNA.
Oligonucleotide primers and probes. Oligonucleotides were
synthesized on an Applied Biosystems 380B DNA synthesizer.
The primers were RNA specific in that both the 5' and 3'
primers span the junctions of 2 exons, thus precluding ampli-
fication of genomic DNA. Sequences for the internal 24-mer
oligonucleotide probes used for hybridization were as follows:
IL-lb, ccatggacaagctgaggaagatgc (2); IL-2, gccacagaactgaaacat
cttcag (30); TNF-a, gttgtagcaaaccctcaagctgag (35); and IFN--y,
gaccagagcatccaaaagagtgtg. The PCR primer sequences for the
cytokines IL-1p, IL-2, TNF-ot, and IFN--y and the control
glyceraldehyde 3-phosphate dehydrogenase (GA3PD) were as
follows: IL-13, aaacagatgaagtgctccttccagg, tggagaacaccacttgtt
gctcca (35); IL-2, gaatggaattaataattacaagaatccc, tgtttcagatccctt
tagttccag (35); TNF-ao, cagagggaagagttccccag, ccttggtctggtag
gagacg (35); IFN-y, gaaatattttaatgcaggtc, gtcagttaccgaataattag
(22); and GA3PD, tggtatcgtggaaggactcatgac, atgccagtgagcttc
ccgttcagc (34). Internal oligonucleotide probes were 3' end
labeled with [t_-32P]dATP and terminal transferase according
to the supplier's protocol (Boehringer Mannheim Biochemi-
cals, Indianapolis, Ind.). Specific activities ranged from 3 x
109 to 1 x 1010 cpm/,ug.
Amplification. RNA was reverse transcribed into cDNA
which was amplified with the GeneAmp RNA-PCR kit (Per-
kin-Elmer Cetus, Norwalk, Conn.). The RT reaction mixture
was incubated for 1 h at 42°C, heated to 99°C for 5 min, to
inactivate the enzyme, and then quick-chilled on ice. PCR was
performed with 30 cycles of 95°C for 1 min (denaturation) and
60°C for 1 min (primer annealing and extension). To normalize
for the amount of input RNA, RT-PCR was performed with
the constitutively expressed gene encoding GA3PD (34).
Southern transfer and hybridization. Equal portions of each
PCR product were subjected to electrophoresis followed by
capillary transfer to nylon membrane (ZetaBind; Cuno Inc.,
Meriden, Conn.) according to previously published procedures
(20, 28). Following transfer, membranes were prehybridized in
6x SSPE (lx SSPE is 0.18 M NaCl, 10 mM NaPO4, and 1
mM EDTA [pH 7.7])-0.1% NaPPi-0.5% sodium dodecyl
sulfate (SDS)-0.5% BLOTTO for 4 to 16 h at 65°C. Hybrid-
ization was performed in 6x SSPE containing 0.1% NaPPi-
0.5% SDS, with 5 x 105 cpm of 32P-labeled internal oligonu-
cleotide probe per ml, for 8 to 12 h at 40°C. Filters were
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FIG. 1. Optimization of quantity of input RNA versus number of
PCR cycles. Results from one of three replicate Southern blots of
different amounts of input RNA (0.0001, 0.001, 0.01, 0.1, and 1 p.g)
assayed by RT-PCR for various numbers of PCR cycles (16, 22, 28, 34,
and 40 in one experiment and 15, 20, 25, 30, 35, and 40 in two
experiments) are shown. Radioactive bands were quantified by elec-
trophoretic analysis imaging and were plotted for assay standardiza-
tion.
washed three times with 6x SSPE-0.1% SDS at room tem-
perature for 15 min each, wrapped in cellophane wrap, and
exposed to X-ray film (Hyperfilm-MP; Amersham Corpora-
tion, Arlington Heights, Ill.) at room temperature with an
intensifier screen.
Quantitative analysis. Figure 1 is a graph of a Southern blot
(one of three) analyzed by densitometry. These data were used
to determine (i) the number of PCR cycles and (ii) the amount
of input RNA such that PCR product formation remained
within a linear range despite a potential 100-fold increase in
the level of cytokine mRNA. To determine the validity of this
approach, three separate experiments were run in which
different amounts of input RNA from ConA-stimulated PB-
MCs (0.0001, 0.001, 0.01, 0.1, and 1 ,ug) were assayed by
RT-PCR for IL-113 for various numbers of PCR cycles (16, 22,
28, 34, and 40 in one experiment and 15, 20, 25, 30, 35, and 40
in two experiments). The amount of product obtained was
proportional to the amount of input RNA. Since a reference
control was used as a standard against which values obtained
from sample RNA were normalized, 0.01 jLg of RNA was
chosen as the quantity of input RNA whose efficiency of
amplification most closely matched that of the control. From
these data, it was determined that an initial quantity of 0.01 p.g
of total RNA per reaction mixture amplified for 30 cycles
would represent a direct measure of cytokine mRNA over a
100-fold range of concentrations. Band intensity was deter-
mined with laser scanning densitometry (Visage 110; Biolmage
Products, Ann Arbor, Mich.). Alternatively, the radioactivity in
each band was determined directly with the BetaScope 603 blot
analyzer (Betagen, Waltham, Mass.), and counts per minute
were extrapolated against those obtained from amplification of
104 copies of RNA construct. The RNA construct (referred to
herein as the reference RNA) contained the 5' and 3' primers
of 12 human cytokine genes connected in sequence with a
downstream polyadenylated sequence and was included in the
RNA-PCR kit as the positive control.
Donors Tested
FIG. 2. PPD-induced lymphoproliferative responses from naive
and sensitized donors and TB patients. PBMCs were cultured at 3 x
105 cells per well in the presence of PPD (5 p.g/ml) for 6 days.
[3H]thymidine incorporation was assessed during the last 6 h of
culture. Values are mean counts per minute ± standard error.
Kinetics of mRNA induction. To determine the kinetics of
induction of cytokine mRNA in this in vitro system, RNA was
extracted from cells at 0, 6, 12, 24, and 48 h of coculture with
either infected or uninfected macrophages from donors repre-
senting the three groups studied. RT-PCR was performed with
0.1 ,ug of total RNA per reaction mixture for the cytokines
IL-1,, IL-2, TNF-ot, IFN-y, and the positive control GA3PD.
We observed two peaks of mRNA accumulation during this
time period which may result from two independent induction
stimuli. In the uninfected cocultures, PCR product for IL-11,
TNF-cx, and IFN-y was visible at 0 through 24 h, with a peak
intensity at 6 h; by 48 h of coculture, there was no visible
product. In M. tuberculosis-infected cocultures, we observed a
similar pattern, with product visible at 0 and 6 h, diminishing in
intensity at 12 h, and then increasing again with a peak at 48 h
(data not shown). Cytokine mRNA present from 0 through 12
h is believed to result from the physical process of cell
separation, manipulation, and adherence. Cytokine mRNA at
48 h of coculture is thought to represent induction by the
intracellular pathogen and was the time point at which RNA
was evaluated for this study.
Statistics. Comparisons between groups were done by Stu-
dent's t test for independent samples. Values of P 2 0.05 were
considered not significant.
RESULTS
Lymphoproliferation and phenotypic analysis. The lympho-
proliferative responses to PPD-stimulated and M. tuberculosis-
infected monocytes of normal naive donors, PPD-responsive
donors, and patients with active TB were compared (Fig. 2). As
expected, normal naive donors demonstrated no thymidine
incorporation in response to PPD, while sensitized individuals
demonstrated extensive proliferation. By comparison, cells
from patients with active TB proliferated much less vigorously
than did cells from healthy sensitized individuals. When NA
cells from the three groups of donors were cocultured withM
tuberculosis H37Rv-infected AD cells, similar proliferative
responses were observed (results not shown). The blastogenic
responses induced by 5 jig of ConA, however, were similar in
all three groups of donors (data not shown).
Phenotypic analysis of the cocultured infected cells from
sensitized donors, patients with active TB, and normal control
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FIG. 3. IL-2 (A) and IFN--y (B) mRNA induction in M. tuberculo-
sis-infected cocultures of cells from naive and PPD-sensitized normal
donors and TB patients. Counts per minute values were normalized to
the reference standard RNA. Horizontal bars represent arithmetic
mean level of transcription for each donor group.
donors revealed no major differences or changes relative to the
starting population, with one exception. We observed an
overall reduction in the percentage of CD28+ T cells during
coculture with infected AD cells in TB patients and PPD
responders compared with their levels at the baseline analysis
(15 and 12% reductions, respectively). These phenotypic
changes were not significant compared with those of normal
naive donors. However, when the percentage of CD28+ cells
and the level of the CD28 antigen expressed on cells of each
individual were compared with the level of IL-2 mRNA
expressed by these cells, an inverse correlation was observed
(described below).
Cytokine mRNA induction in cocultured cells. The level of
IL-2 mRNA induced in the cells by coculture with H37Rv-
infected AD cells is demonstrated in Fig. 3A. As expected, cells
from naive donors that did not proliferate in response to either
PPD or mycobacterium-infected AD cells demonstrated the
lowest levels of IL-2 mRNA. Cells from sensitized healthy
donors expressed various levels of IL-2 mRNA, with a mean
mRNA copy number about 30-fold higher than that observed
in patients with active disease. In general, cells from patients
with active TB expressed lower levels of IL-2 mRNA than did
those from PPD-sensitized healthy donors: half of them were
as low as those of normal naive donors, and half were within
the range of those of the sensitized individuals. Within the
group of sensitized normal and active TB patients, the T cells
from the individuals with the lowest levels of IL-2 mRNA
expression also demonstrated the highest levels of the CD28
antigen. As the amount of IL-2 mRNA expressed by the cells
increased, a reduction in CD28 antigen expression was ob-
served. The IL-2 mRNA levels observed in the cells correlated
with the extent of thymidine incorporation observed in these
groups of donors (Fig. 2).
In contrast, levels of IFN--y mRNA (Fig. 3B) did not
correlate with PPD responsiveness or disease status. Cells from
normal naive individuals were induced by exposure-to infected
monocytes to produce levels of IFN--y mRNA as high as those
observed in sensitized healthy donors, while cells from TB
patients demonstrated somewhat (10-fold) reduced levels of
IFN--y mRNA compared with those from PPD-sensitized
healthy donors. The differences observed were not statistically
significant by the binomial test (at P > 0.1) because of the
broad range of values obtained. However, this general trend is
suggestive of an IFN-y production defect in patients with
active disease.
Quantitation of mRNA expression of the monocyte cyto-
kines IL-1 and TNF-ot (Fig. 4) demonstrated a distribution
similar to that observed with IL-2 mRNA. Cells from naive
donors expressed the lowest levels of cytokine mRNA, while
cells from healthy sensitized donors and TB patients expressed
a wider range of levels, with normal sensitized individuals' cells
expressing much higher mRNA levels than those from naive
donors. As mentioned above, these results are of interest but
are not statistically significant (at P > 0.1).
The cytokine mRNA responses to ConA stimulation of cells
were similar in the three groups of donors and mirrored the
extent of thymidine incorporation in ConA-stimulated cultures
(Fig. 5).
DISCUSSION
The model presented here was designed to monitor subtle
changes in T-cell subpopulation numbers and cytokine gene
induction in response to infection with live, virulent M. tuber-
culosis. Therefore, we employed physiologically relevant pa-
rameters, including a low multiplicity of infection, autologous
serum, the absence of exogenously added lymphokines, and a
T-celllmonocyte ratio which allowed continued cellular differ-
entiation over a 7-day coculture period. We then evaluated
differences in immune response parameters to in vitro infec-
tion among cells from normal naive individuals, PPD-sensi-
tized donors, or TB patients in this coculture model. We found
that, despite the extensive mycobacterial antigenic load which
is likely to occur in patients with active TB, T cells obtained
from such individuals demonstrated reduced proliferative re-
sponses as well as relatively low levels of cytokine mRNA
expression compared with those from normal healthy PPD-
sensitized individuals. It has been reported that TB patients
with newly diagnosed pulmonary disease have defective PPD-
stimulated but normal streptococcal antigen-stimulated IL-2
production compared with healthy responders (1, 32). In the
present study, similar observations were made with the cells of
patients who had been on anti-TB drug therapy for relatively
VOL. 62, 1994
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FIG. 5. Mitogen-induced cytokine mRNA levels. PBMCs from the
three donor groups were stimulated for 6 h with 10 ,ug of ConA per ml
followed by RNA extraction and RT-PCR analysis for IL-2, IFN-y,
IL-1,B, and TNF-ot. Horizontal bars represent arithmetic mean value
for each donor group.
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FIG. 4. IL-1l (A) and TNF-ot (B) transcription levels in M. tuber-
culosis-infected cocultures of cells from naive and PPD-sensitized
donors and TB patients. Horizontal bars represent arithmetic mean
level of mRNA transcripts for each donor group.
long periods of time. Five of 11 patients studied here were
chronic TB patients exhibiting positive sputum smears despite
a mean duration of therapy of 12 months. This suggests that
T-cell unresponsiveness occurs in chronically treated patients
as well as in newly diagnosed patients and is not alleviated by
long-term drug therapy.
It was surprising that cells from naive donors that did not
proliferate in response to mycobacterial antigens and did not
express the T-cell-specific cytokine IL-2 did express significant
levels of IFN-y mRNA. IFN--y is a cytokine known to be
produced by activated ct3T cells as well as activated y8T cells
and NK cells (25). Our observations suggest that NK cells or
possibly -y6T cells from naive donors are the likely source of
IFN--y mRNA in the cocultured peripheral blood cells. The
relatively lower amount of IFN--y mRNA expressed by cells
from TB patients corresponds to the reduced proliferative
response and could result from reduced T-cell activation
and/or reduced NK cell activation.
The inverse relationship between CD28 expression and the
amount of IL-2 mRNA induction in these primary cell cultures
corroborates previous observations by Rotteveel et al. (27)
who demonstrated that low levels of CD28 expression of T-cell
clones coincided with expression of the TH1 lymphokines IL-2
and IFN-y and anti-CD3-mediated cytotoxicity. Conversely,
CD4+ clones with high levels of CD28 expression produced
low levels of lymphokines and were not cytotoxic. The CD28
surface molecule is involved in the very complex signal trans-
duction pathway which modulates lymphokine production.
Stimulation of T cells via CD3 plus CD28 leads to high levels
of cytokine mRNA and prolonged secretion of inflammatory
cytokines, including IL-2, IFN--y, TNF-ot, granulocyte macro-
phage-colony-stimulating factor, and colony-stimulating factor
1. This is due to stabilization of certain mRNA transcripts and
regulation of transcriptional initiation through CD28 stimula-
tion (12).
Using this in vitro model of macrophage-lymphocyte inter-
action employing AD cells infected with virulent M. tubercu-
losis H37Rv, we have presented results which concur with
those obtained in previous studies which used animal models
of disease and/or avirulent organisms or mycobacterial anti-
gens. Because of the carefully defined and controlled condi-
tions of the coculture model, very subtle changes in T-cell
subpopulation numbers and levels of cytokine induction were
observed. Furthermore, with the sensitive PCR technique, we
report the decreased induction of cytokines by TB patient cells
in response to mycobacterial infection as expressed at the level
of mRNA transcription. This assay allows the detection of
small differences in mRNA quantity between individuals who
differ in their anti-mycobacterial immune status. The cytokine
profiles presented here suggest that patients with active TB
manifest reduced activity at the T-cell, monocyte, and NK cell
level compared with presensitized normal individuals. De-
creased IFN--y induction in response to M. tuberculosis infec-
tion may lead to diminished macrophage activation and a more
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permissive environment for the bacterium. It was recently
reported that PBMCs from patients with active TB, as well as
those from lepromatous leprosy- and human immunodefi-
ciency virus type 1-infected individuals, display decreased NK
cell numbers and activity compared with those from normal
control subjects (13, 31). Following low-dose IL-2 treatment,
the leprosy patient NK cell numbers in PBMCs increased
sixfold; IL-2 therapy of human immunodeficiency virus pa-
tients resulted in enhanced NK and lymphocyte-activated killer
cell activity in vitro, without significant changes in the number
or percentage of CD56+ or IL-2R+ cells in PBMCs. Since NK
cells produce a number of cytokines, including IFN--y, IL-2,
and TNF-cx, they may make a significant contribution to the
development of a successful immune response within the
infected tissue milieu. Since we amplified cytokine mRNA
from a mixture of cells, it is not possible to assign a contribu-
tion to each cell type. The next step in this study will be to sort
cells and determine the role of each leukocyte subpopulation
in the cytokine response to viable M. tuberculosis. Investiga-
tions focusing on NK cell function and cytokine regulation in
patients with active tuberculosis are under way.
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